This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Scancell Limited, Other. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12 
1 out of 834,513 Years Active: 2020-2026
Title: Mireille Vankemmelbeke: Innovator in Cancer Treatment
Introduction
Mireille Vankemmelbeke is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of cancer treatment through her innovative research and development. With a focus on specific binding members for cancer therapy, her work has the potential to impact many lives.
Latest Patents
Mireille holds 1 patent titled "Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto." This invention relates to an isolated specific binding member capable of binding sialyl-di-Lewis, along with associated treatments and pharmaceutical compositions for cancer treatment.
Career Highlights
Throughout her career, Mireille has worked with various organizations, including Scancell Limited. Her expertise in the field has allowed her to develop groundbreaking solutions aimed at improving cancer therapies.
Collaborations
Mireille has collaborated with esteemed colleagues such as Lindy Gillian Durrant and Silvana Tivadar. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Mireille Vankemmelbeke's contributions to cancer treatment through her innovative patents and collaborations highlight her dedication to advancing medical science. Her work continues to inspire and pave the way for future innovations in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile